Antitumor effects of azaserine and DON.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001377:Azaserine / Q000008:administration & dosage*; D001391:Azo Compounds / Q000008:administration & dosage*; D003980:Diazooxonorleucine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D001391:Azo Compounds; D003980:Diazooxonorleucine; D001377:Azaserine